Latest News

Common multiple sclerosis drugs taken together do not reduce relapse risk

A recent clinical trial found that interferonβ-1a (INF) and glatiramer acetate (GA), two of the most commonly prescribed drugs for multiple sclerosis (MS), provide no additional clinical benefit when taken together. While findings suggest that taking both INF and GA together was not superior to GA monotherapy in reducing relapse risk; the combination therapy does appear to reduce new lesion activity and total lesion volume.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Fear, safety and the role of sleep in human PTSD: Fragmented REM sleep may hinder effective treatment

  • Study reveals drivers of Western consumers' readiness to eat insects

  • Computer games give a boost to English

  • How nerve cells communicate with each other over long distances: Travelling by resonance

  • Serotonin deficiency? Study throws into question long-held belief about depression

  • Marijuana compound may offer treatment for Alzheimer's disease, study suggests

  • Gang life brings deep health risks for girls

  • First study of brain activation in multiple sclerosis using fNIRS

  • Readers with dyslexia have disrupted network connections in the brain, map the circuitry of dyslexia shows

  • Avatars make the Internet sign to deaf people

  •